Latest Advances in Lung Cancer Research

Expanding lung cancer screening to those aged 50-80 with 20 pack-year smoking history could increase eligibility by 87%, reducing disparities and saving lives.

The Veterans Health Administration promotes lung cancer screening with low-dose CT scans for eligible veterans aged 50-80 with a 20+ pack-year smoking history.

Scientists develop a groundbreaking urine test that detects “zombie” cell proteins, enabling early detection of lung cancer and potentially improving patient outcomes and prognosis.

CDI scientists publish groundbreaking papers on lung cancer breath test and immune system’s role in fighting diseases. These discoveries could revolutionize cancer detection and treatment, potentially improving patient outcomes.

Lung cancer screening significantly increases early detection and survival rates for at-risk US veterans, a new study finds.

“Ground-glass opacity” on lung CT scans, a hazy sign of potential cancer, is linked to higher survival rates, emphasizing the importance of early detection.

Women’s lung cancer is often diagnosed late and treated less aggressively than men’s lung cancer, despite being the leading cause of cancer death among women.

Study finds lung cancer patients show distinct lung microbiome profiles versus benign diseases. Analyzing microbial features in bronchoalveolar lavage fluid could serve as minimally invasive biomarker for lung cancer detection, reducing need for biopsies.

Ohio State launched a mobile lung cancer screening unit to increase early detection statewide by bringing expert staff & the latest diagnostic tech to underserved areas. The goal is to boost screening rates.

Changing the current lung cancer guidelines to a 2-year smoking duration cutoff vs a 20 pack-year cutoff would significantly improve the rate of cancer detection and reduce racial disparities with screenings.

Artificial intelligence (AI) assessments of chest X-rays identified 28% of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference.

UCLA researchers received a $6 million grant to refine a liquid biopsy blood test for early, accurate lung cancer detection and treatment guidance.